Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BIO-TECHNE Corp (TECH) vs Tempus AI (TEM) Price & Performance

BIO-TECHNE CorpTrade
Tempus AITrade

Price performance (Past 24H)

Key statistics

BIO-TECHNE Corp vs Tempus AI — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Tempus AI trades at $49.01 (market cap $8.69B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

TECHTEM
Market Cap
$11.16B$8.69B
Sector
HealthBroad Market / Factor
52-Week High
$72.12$103.25
52-Week Low
$43.31$42.37
Enterprise Value
$11.24B$9.37B
Dividend Yield
0.45%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM